Congress delegates are invited to submit abstracts of their scientific work for presentation as a free communication at Worldlab Durban 2017.
An unlimited number of abstracts may be submitted provided the presenting author applies for “full registration”. Abstracts are welcome in all fields of clinical chemistry, haematology, clinical molecular biology and laboratory medicine, in the broader sense. Free communications are primarily presented via poster. A limited number of abstracts will be selected for oral presentation during symposia (two abstracts for each symposium). Authors wishing to compete for these oral communication slots should mark the appropriate field on the on-line abstract-submission form. Properly submitted abstracts will be sent to experts for review and selection for oral communication.
1. Advance glycation endproducts in diabetes mellitus and chronic disease
2. Advanced Glycation End Products (AGEs) in diabetes mellitus and chronic diseases
3. Advances in TB diagnostics
4. Affordable diagnostics for Africa
5. Alzheimer’s Disease
6. Applying big Data to Improve Laboratory Practice
7. Big data and metabolomics
8. Biomarkers in cancer/ Circulating tumour markers
9. Biomarkers in precision medicine
10. Bridging the gaps between laboratory medicine & clinical decision making: challenges and conundrums
11. Clinical Laboratory Practice for Bone Turnover markers
12. Emerging challenges of Laboratory Medicine
13. Evidence-based laboratory medicine
14. Frontiers in endocrinology
15. High sensitivity cardiac troponin assays
17. Implementing Cancer Genomics in Low Resource Settings
18. Improvement in clinical laboratory services: Approaches to adding value
19. Infections and diabetes
20. Interpretation and Commenting on Clinical Chemistry Results: An interactive workshop
21. ISO accreditation and quality assurance
22. Laboratory Reference Intervals: Global Initiatives and Harmonization challenges
23. Liquid biopsy and circulating free plasma DNA
24. Metabolomics and biomarkers
26. Personalized and precision medicine
28. Pre and Post analytical quality
29. Recent advances in Standardization
30. Risk Management and its utility in the clinical laboratory
31. Standardization in laboratory medicine beyond clinical chemistry
32. Strategic Planning for Evaluation and Assessment of Internal and External quality control Performance
33. Traceability in laboratory medicine
34. Training programmes for biomedical scientists and laboratory medicine specialist
35. Value of Laboratory Medicine in Healthcare Delivery
The text must be clear, concise, and written in proper English. The content must not have been previously published in academic journals or subject to peer review. Significant technical information must not be withheld. Abstracts must absolutely contain results. Statements such as “results will be discussed” are not acceptable and will lead to rejection.
STRUCTURE OF THE ABSTRACT
Abstracts can be structured and must include:
a brief introduction stating the purpose of the investigation and its relevance to laboratory medicine;
a description of the methodology used;
to be supported by statistical or other evidence to show their validity;
The body of the abstract must not exceed 2300 characters, spaces included.
Deadline for receipt: Abstracts should be submitted by 31st May 2017, 23:59 CET
Confirmation of receipt: Receipt of the abstract will be acknowledged by e-mail immediately after submission.
Notification of acceptance or rejection: Authors will be notified of acceptance or rejection before 15th July 2017
Registration: The presenting author of each abstract must register for the congress with “Full Registration”.
Abstract authors are asked to indicate the most suitable topic for presentation of their work and will also be asked whether they wish apply for an oral presentation during the scientific symposia. In that case, authors must also select the symposium in which they would like to give their presentation.